Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Glatopa

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Abstract Objective: To compare relapse rates and healthcare costs in MS patients treated with Glatopa 20 mg (generic glatiramer… Expand
Is this relevant?
Review
2017
Review
2017
Background: In April 2015, the US Food and Drug Administration approved the first generic glatiramer acetate, Glatopa® (M356), as… Expand
  • table 1
Is this relevant?
Review
2015
Review
2015
Glatiramer acetate (GA) has been available under the brand name Copaxone® for nearly two decades. Recently, the US Food and Drug… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Glatopa™ is a generic glatiramer acetate recently approved for the treatment of patients with relapsing forms of multiple… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?